Publikationen Dr. Vladimir Purvanov
-
Artinger M, Gerken OJ, Purvanov V, Legler DF. 2022. Distinct Fates of Chemokine and Surrogate Molecule Gradients: Consequences for CCR7-Guided Dendritic Cell Migration. Front Immunol 13:913366. doi: 10.3389/fimmu.2022.913366.
- Uetz-von Allmen E, Samson GPB, Purvanov V, Maeda T, Legler DF. 2021. CAL-1 as cellular model system to study CCR7-guided human dendritic cell migration. Front Immunol Sep 16;12:702453. doi: 10.3389/fimmu.2021.702453.
- James KD, Legler DF, Purvanov V, Ohigashi I, Takahama Y, Parnell SM, White AJ, Jenkinson WE, Anderson G. 2021. Medullary stromal cells synergize their production and capture of CCL21 for T-cell emigration from neonatal mouse thymus. Blood Adv Jan 12;5(1):99-112. doi: 10.1182/bloodadvances.2020003192.
- Matti C, D'Uonnolo G, Artinger M, Melgrati S, Salnikov A, Thelen S, Purvanov V, Strobel TD, Spannagel L, Thelen M, Legler DF. 2020. CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4. J Leukoc Biol Jun;107(6):1137-1154. doi: 10.1002/JLB.2MA0420-295RRR.
- Laufer JM, Hauser MA, Kindinger I, Purvanov V, Pauli A, Legler DF. 2019. Chemokine Receptor CCR7 Triggers an
Endomembrane Signaling Complex for Spatial Rac
Activation. Cell Rep 29(4):995-1009. e6, October 22, 2019.
- Jakobs BD, Spannagel L, Purvanov V, Uetz-von Allmen E, Matti C, Legler DF. 2019. Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7. Int J Mol Sci Int J Mol Sci. 2019 May 27;20(10). pii: E2597. doi: 10.3390/ijms20102597. Repository
- Purvanov V, Matti C, Samson GPB, Kindinger I, Legler DF. 2018. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions. Int J Mol Sci Dec 4;19(12). pii: E3876. doi: 10.3390/ijms19123876.
- Nyffeler J, Chovancova P, Dolde X, Holzer AK, Purvanov V, Kindinger I, Kerins A, Higton D, Silvester S, van Vugt-Lussenburg BMA, Glaab E, van der Burg B, Maclennan R, Legler DF, Leist M. 2018. A structure-activity relationship linking non-planar PCBs to functional deficits of neural crest cells: new roles for connexins. Arch Toxicol Mar;92(3):1225-1247. doi: 10.1007/s00204-017-2125-4. Epub 2017 Nov 21.
- Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Chaucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B. 2017. Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4. FASEB J 31:3084-3097.
- Legler DF, Matti C, Laufer JM, Jakobs BD, Purvanov V, Uetz-von Allmen E, Thelen M. 2017. Modulation of chemokine receptor function by cholesterol: new prospects for pharmacological intervention. Mol Pharmacol 91(4):331-338.
- Lüchtenborg AM, Purvanov V, Melnik BS, Becker S, Katanaev VL. 2015. Mode of interaction of the Gαo subunit of heterotrimeric G proteins with the GoLoco1 motif of Drosophila Pins is determined by guanine nucleotides.
Biosci Rep Oct 20. pii: BSR20150201. [Epub ahead of print].
- Purvanov V, Holst M, Khan J, Baarlink C, Grosse R. 2014. G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion.
ELIFE Jun 20;3. doi: 10.7554/eLife.02786.
- Koval A, Purvanov V, Egger-Adam D, Katanaev VL. 2011. Yellow submarine of the Wnt/Frizzled signaling: submerging from the G protein harbor to the targets.
Biochem Pharmacol 82(10):1311-1319.
- Purvanov V, Koval A, Katanaev VL. 2010. A direct and functional interaction between Go and Rab5 during G protein-coupled receptor signaling.
Sci Signal 3(136):ra65. doi: 10.1126/scisignal.2000877.
- Koval A, Kopein D, Purvanov V, Katanaev VL. 2010. Europium-labeled GTP as a general nonradioactive substitute for [(35)S]GTPgammaS in high-throughput G protein studies.
Anal Biochem 397(2):202-207.
- Purvanov V, Fetzner S. 2005. Replacement of active-site residues of quinoline 2-oxidoreductase involved in substrate recognition and specificity.
Curr Microbiol 50(4):217-222.
- Bonin I, Martins BM, Purvanov V, Fetzner S, Huber R, Dobbek H. 2004. Active site geometry and substrate recognition of the molybdenum hydroxylase quinoline 2-oxidoreductase.
Structure 2(8):1425-1435.